Less instrumentation. More insight. Physics-informed virtual sensors are shifting condition monitoring from isolated pilots ...
Visitors may believe they freely choose what to see in a museum, but new research shows that design decisions, often ...
According to Saurabh Prasad of In2IT Technologies, cyber defence is no longer optional in the age of quantum computing and ...
Cambridge, Massachusetts, January 14, 2025 - Insilico Medicine (“Insilico”, HKEX:03696), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the ...
Modern smart collars have evolved from simple GPS trackers to sophisticated biometric instruments capable of early disease ...
Trends such as industry-specific AI and a new data economy will affect physical AI in 2026, says a Universal Robots executive ...
A team of industry leaders and the University of North Dakota are targeting the nation’s $966 billion chronic disease ...
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...
Artificial intelligence (AI) is increasingly used to analyze medical images, materials data and scientific measurements, but ...
The partnership extension builds on a successful collaboration focused on helping operators move beyond traditional CRM and ...
Zacks Investment Research on MSN
RVTY & Eli Lilly partner to expand access to AI drug discovery models
Revvity, Inc. RVTY recently announced a collaboration with Eli Lilly and Company to make Eli Lilly’s TuneLab predictive ...
Tempus, a leader in artificial intelligence and precision medicine, and NYU Langone Health, one of the nation's premier academic medical centers, today announced a multi-year strategic collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback